Supply Chain
Future-Proofing a Volatile Supply Chain Through Modular Biomanufacturing
John Stewart; Rasmus Pedersen, Ph.D.; Peter Skals
Fujifilm Biotechnologies
PAO-06-25-CL-03Jul 07, 2025
Clinical Research
TCBP Awarded Non-Dilutive Funding, ScaleReady's G-Rex® Grant
TC Biopharm
PR-10-24-NI-55Oct 22, 2024
Risk Management in mRNA Manufacture
Managing Risk in Cutting-Edge mRNA Therapeutics
Jessica Madigan; Normand Blais
BIOVECTRA
PAO-07-23-CL-04Jul 31, 2023
Cloud Regulatory Compliance
Cloud Control: Maintaining Compliance as Regulated Apps Move Off Premise
Thierry Dietrich, Ph.D.
PAO-07-022-CL-08Jul 19, 2022
CAPA Management
CAPA Management is Worth Doing, and Worth Doing Well
Helen Lowe
PAO-04-022-CL-11May 04, 2022
Supply Chain Quality Management
Digitalizing Quality Management: What the Food Industry Can Teach Pharma
Gaëlle Jaron
PAO-04-022-CL-12Apr 29, 2022
New Leadership
CRB Announces Courtney Holt as New General Counsel
CRB
PR-M02-22-16Feb 17, 2022
Cell and Gene Therapy
Reducing the Risk During Cell and Gene Therapy Development and Manufacturing
MilliporeSigma
PAO-03-21-CL-9Mar 24, 2021
Roundtable
Q: Although there is no such thing as a truly “crisis-proof” organization, how are you working to mitigate risks for future crises like the COVID-19 pandemic?
Pharma's Almanac
PAP-Q4-20-NI-007Dec 09, 2020
Risk Management
The Value Triangle: Risk Management for RMATs
John Wass
CAI Commissioning Agents Inc.
PAP-Q1-2019-CL-018Mar 12, 2019